Medical News

---

• Stroke risk rises after aspirin discontinuation
• Hearing impairment may increase psychosis risk in young people
• Cannabis use prevalent in bipolar disorder patients
• Anticoagulants may reduce cancer incidence in older adults
• CHA₂DS₂-VASc pinpoints ‘truly low-risk’ patients
• Low HDL cholesterol enhances anti-cancer effect of metformin
• Anticoagulants may reduce cancer incidence in older adults
• Less xerostomia after IMRT versus conventional RT for head and neck cancer
• Low HDL cholesterol enhances anti-cancer effect of metformin
• ‘Metabolically obese’ at increased CVD risk
• Proportion treated for high cholesterol ‘disappointingly low’
• Low HDL cholesterol enhances anti-cancer effect of metformin
• NODAT risk reduced by steroid-free therapy after kidney transplant
• Folic acid may lower risk for first, not second MI

Stroke risk rises after aspirin discontinuation Posted: 07 Feb 2011 04:00 PM PST Patients with cardiovascular or cerebrovascular disease have an increased risk for stroke for 6 months after they discontinue long-term treatment with aspirin, a large study shows.

Hearing impairment may increase psychosis risk in young people Posted: 07 Feb 2011 04:00 PM PST Hearing impairment is associated with an increased risk for psychotic symptoms in young people, study results suggest.

Cannabis use prevalent in bipolar disorder patients Posted: 07 Feb 2011 04:00 PM PST Cannabis use is significantly more common among patients with bipolar disorder (BD) than those of similar age, gender, and ethnicity in the general population who do not have the mood condition, researchers report.

Anticoagulants may reduce cancer incidence in older adults Posted: 06 Feb 2011 04:00 PM PST Older people who use vitamin K antagonists are less likely to develop cancer than those who have never taken this type of anticoagulant, Italian research shows.

CHA<sub>2</sub>DS<sub>2</sub>-VASc pinpoints ‘truly low-risk’ patients Posted: 06 Feb 2011 04:00 PM PST The CHA2DS2-VASc scheme allows accurate refinement of risk among atrial fibrillation patients at low or intermediate risk for stroke according to the CHADS2 scheme, shows a study published in the BMJ.

Low HDL cholesterol enhances anti-cancer effect of metformin Posted: 06 Feb 2011 04:00 PM PST Research suggests that the previously reported anti-cancer effect of metformin treatment is most apparent in patients with Type 2 diabetes who also have low levels of high-density lipoprotein cholesterol.

Anticoagulants may reduce cancer incidence in older adults Posted: 06 Feb 2011 04:00 PM PST Older people who use vitamin K antagonists are less likely to develop cancer than those who have never taken this type of anticoagulant, Italian research shows.

Less xerostomia after IMRT versus conventional RT for head and neck cancer Posted: 06 Feb 2011 04:00 PM PST Head and neck cancer patients treated with intensity-modulated radiotherapy, which spares the parotid glands, experience significantly less post-treatment xerostomia compared with their counterparts who are treated with conventional radiotherapy, say researchers.

Low HDL cholesterol enhances anti-cancer effect of metformin Posted: 06 Feb 2011 04:00 PM PST Research suggests that the previously reported anti-cancer effect of metformin treatment is most apparent in patients with Type 2 diabetes who also have low levels of high-density lipoprotein cholesterol.

‘Metabolically obese’ at increased CVD risk Posted: 06 Feb 2011 04:00 PM PST Researchers say that normal-weight individuals with cardiometabolic abnormalities are at higher risk for future cardiovascular disease than obese people who are metabolically healthy.

Proportion treated for high cholesterol ‘disappointingly low’ Posted: 06 Feb 2011 04:00 PM PST Effective treatment for people with high cholesterol remains low in many countries, shows an analysis of eight National Health Examination surveys.

Low HDL cholesterol enhances anti-cancer effect of metformin Posted: 06 Feb 2011 04:00 PM PST Research suggests that the previously reported anti-cancer effect of metformin treatment is most apparent in patients with Type 2 diabetes who also have low levels of high-density lipoprotein cholesterol.

NODAT risk reduced by steroid-free therapy after kidney transplant Posted: 06 Feb 2011 04:00 PM PST The risk for developing new-onset diabetes after transplant following kidney transplantation is significantly reduced by the adoption of a steroid-free maintenance immunosuppression regimen, report researchers.

Folic acid may lower risk for first, not second MI Posted: 06 Feb 2011 04:00 PM PST Meta-analysis findings suggest that folic acid supplementation may reduce an individual's risk for a primary but not secondary ischemic heart disease event, such as a myocardial infarction.

You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610